Woodline Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93M | Hold |
4,360,608
| – | – | 0.03% | 560 |
|
|
2025
Q1 | $6.37M | Buy |
4,360,608
+376
| +0% | +$549 | 0.04% | 445 |
|
|
2024
Q4 | $9.29M | Sell |
4,360,232
-4,068
| -0.1% | -$8.67K | 0.06% | 360 |
|
|
2024
Q3 | $12.2M | Buy |
4,364,300
+5,311
| +0.1% | +$14.9K | 0.1% | 264 |
|
|
2024
Q2 | $10.2M | Buy |
4,358,989
+1,725,013
| +65% | +$4.02M | 0.1% | 244 |
|
|
2024
Q1 | $11.8M | Buy |
2,633,976
+56,476
| +2% | +$252K | 0.11% | 236 |
|
|
2023
Q4 | $8.27M | Sell |
2,577,500
-2,736,415
| -51% | -$8.78M | 0.09% | 248 |
|
|
2023
Q3 | $16.8M | Buy |
5,313,915
+415
| +0% | +$1.32K | 0.2% | 152 |
|
|
2023
Q2 | $26.4M | Buy |
5,313,500
+3,121,070
| +142% | +$15.5M | 0.31% | 94 |
|
|
2023
Q1 | $10.8M | Sell |
2,192,430
-729,032
| -25% | -$3.6M | 0.15% | 186 |
|
|
2022
Q4 | $18.4M | Sell |
2,921,462
-1,604,960
| -35% | -$10.1M | 0.25% | 124 |
|
|
2022
Q3 | $48.9M | Sell |
4,526,422
-1,333,257
| -23% | -$14.4M | 0.68% | 25 |
|
|
2022
Q2 | $66.8M | Buy |
5,859,679
+5,427,529
| +1,256% | +$61.9M | 1.03% | 7 |
|
|
2022
Q1 | $3.94M | Sell |
432,150
-67,945
| -14% | -$619K | 0.06% | 270 |
|
|
2021
Q4 | $7.46M | Sell |
500,095
-312,635
| -38% | -$4.66M | 0.11% | 233 |
|
|
2021
Q3 | $20.9M | Buy |
812,730
+127,975
| +19% | +$3.29M | 0.34% | 77 |
|
|
2021
Q2 | $17.9M | Buy |
684,755
+12,111
| +2% | +$316K | 0.33% | 81 |
|
|
2021
Q1 | $23.7M | Buy |
672,644
+105,105
| +19% | +$3.71M | 0.53% | 59 |
|
|
2020
Q4 | $14.3M | Buy |
567,539
+167,306
| +42% | +$4.22M | 0.38% | 83 |
|
|
2020
Q3 | $15.1M | Buy |
400,233
+271,605
| +211% | +$10.2M | 0.49% | 57 |
|
|
2020
Q2 | $5.51M | Buy |
+128,628
| New | +$5.51M | 0.22% | 106 |
|